PRKN and Parkinson disease: Loss-of-function mutations in PRKN (a.k.a. PARK2) in D. melanogaster, either by knockout or RNAi knockdown, leads to the disruption of mitochondrial function, increased cellular sensitivity to oxidative stress, and phenotypical locomotor defects, similar to the clinical features of PD (32, 33).